The relationship between emotion dysregulation and sleep in children and adolescents with ADHD: protocol for a systematic review
IntroductionOver half of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) have difficulties with emotion dysregulation (EDR) and/or sleep, yet the interrelations between emotional regulation and sleep are not well-characterised in this population. This systematic review...
Saved in:
Published in | BMJ open Vol. 15; no. 5; p. e099096 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
27.05.2025
BMJ Publishing Group LTD BMJ Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | IntroductionOver half of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) have difficulties with emotion dysregulation (EDR) and/or sleep, yet the interrelations between emotional regulation and sleep are not well-characterised in this population. This systematic review will address the relationship between these difficulties and investigate whether specific aspects of EDR are more strongly related to sleep problems in youth with ADHD.Methods and analysisWe will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guideline for systematic reviews. A wide set of electronic databases will be searched for peer-reviewed quantitative studies investigating the relationship between EDR and sleep in children and adolescents (ages 5 to 18 years) with ADHD. In addition, the reference list of all studies will be searched for other relevant studies, and Scopus will be used to search for citations of the included studies. We will also contact experts in the field to request published and unpublished studies. The primary outcome will be the effect size of the relationship between EDR and sleep in children and adolescents with ADHD. We will look at EDR and sleep broadly and also consider the multifaceted nature of both terms. Secondary outcomes will include which facets of EDR and sleep have been measured and how they have been measured, developmental differences between children and adolescents with ADHD and how—and the extent to which—studies controlled for the use of CNS medications and cooccurring disorders in their study design and/or statistical analyses. The quality and risk of bias of the included studies will be assessed using the Mixed Methods Appraisal Tool.Ethics and disseminationThis protocol is for a review of studies and does not involve any new data collection and therefore does not need ethical or human subjects approval. The results will be presented at international conferences and in a peer-reviewed journal.PROSPERO registration numberCRD42024612984. |
---|---|
Bibliography: | Protocol ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 LS receives editorial honoraria as Associate Editor of Journal of the International Neuropsychological Society (JINS) and received a small research funding for speaking and conference support from Medice in 2023. In the past year, Stephen Becker discloses grant funding from the Institute of Education Sciences (IES), US Department of Education; National Institute of Mental Health (NIMH); and Cincinnati Children’s Research Foundation (CCRF) and has received book honoraria from Guilford Press, editorial honoraria as Joint Editor of JCPP Advances, grant review panel honoraria from the IES and educational seminar speaking fees and continuing education course royalties from PESI and J&K Seminars. All other authors have no competing interest to declare. Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise. SPB and EF-G are joint senior authors. |
ISSN: | 2044-6055 2044-6055 |
DOI: | 10.1136/bmjopen-2025-099096 |